Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
Assessing potential of psilocybin for depressive disorders
HTML
Details
Locations
Year:
2023
Type:
review
Source:
Expert Opinion on Investigational Drugs
DOI:
10.1080/13543784.2023.2273493
Authors:
Zofia Kozak,
Matthew W. Johnson,
Scott T. Aaronson
Institutions:
University of Maryland, Baltimore,
Johns Hopkins University,
Johns Hopkins Medicine,
Sheppard and Enoch Pratt Hospital
Language:
English
Topic:
Psychedelics and Drug Studies
Subfield:
Clinical Psychology
Field:
Psychology
Domain:
Social Sciences
Keywords:
psilocybin,
depression,
treatment-resistant depression,
psychedelic therapy,
clinical trials,
benefits and risks,
antidepressant efficacy
show all 7
SDG:
Good health and well-being
Open Access status:
closed
OpenAlex ID:
W4387866078
FWCI:
0.411
Cites:
75
Cited by:
12
Related to:
10